American Medical Association adopts new policy to ensure diversity in clinical trials and research
June 18th 2024The new policy will work to encourage grant-making entities to fund post-market research investigating pharmacodynamics and pharmacokinetics for generic drugs that did not adequately enroll women, and sexual and gender minority populations in their clinical trials.